Spero Therapeutics Inc. Common Stock (SPRO)

About SPRO

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

sperotherapeutics.com/

Fundamentals

Market cap

$73.53M

P/E (trailing)

4.73

P/E (forward)

—

EPS (trailing)

$0.17

Dividend yield

—

Beta

1.49

Avg. volume

—

Spero Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• SPRO

  Spero Therapeutics Inc. Common Stock

  $1.2

  ▼ 0.83%
  Market cap $73.53MP/E 4.73
  $1.08$3.08
• ACET

  Adicet Bio Inc. Common Stock

  $9.05

  ▲ 0.44%
  Market cap $74.13MP/E —
  $6.01$17.44
• OSTX

  OS Therapies Incorporated Common Stock

  $1.64

  ▼ 2.38%
  Market cap $74.23MP/E —
  $1.15$2.54
• ACRV

  Acrivon Therapeutics Inc. Common Stock

  $2.06

  ▼ 4.19%
  Market cap $72.33MP/E —
  $1.27$3.56
• ELTX

  Elicio Therapeutics Inc. Common Stock

  $2.86

  ▼ 4.67%
  Market cap $72.28MP/E —
  $2.66$16
• CYPH

  Cypherpunk Technologies Inc. Common Stock

  $1.71

  ▼ 9.52%
  Market cap $71.74MP/E —
  $0.27$3.7
• NMAD

  Nomad Power Solutions Inc. Common Stock

  $4.33

  ▼ 2.04%
  Market cap $75.50MP/E —
  $3.12$7.7

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Spero Therapeutics Files Prospectus To Offer Up To $300M In Securities
  benzinga · 8/28/2026

Institutional Ownership

March 31, 2026

Total shares held

20.53M

Total value held

$47.36M

Institutional holders

47